- Report
- October 2022
- 270 Pages
Global
From €2472EUR$2,813USD£2,155GBP
€3297EUR$3,750USD£2,873GBP
- Report
- April 2022
- 326 Pages
Global
From €2472EUR$2,813USD£2,155GBP
€3297EUR$3,750USD£2,873GBP
- Report
- March 2024
- 183 Pages
Global
From €3116EUR$3,545USD£2,716GBP
€3463EUR$3,939USD£3,018GBP
- Report
- October 2022
- 118 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- November 2024
- 100 Pages
Global
From €2189EUR$2,490USD£1,908GBP
- Report
- August 2023
- 250 Pages
Global
From €2189EUR$2,490USD£1,908GBP
- Report
- January 2023
- 50 Pages
China
From €2637EUR$3,000USD£2,299GBP
- Report
- August 2019
- 30 Pages
China
From €1934EUR$2,200USD£1,686GBP
- Report
- October 2023
- 145 Pages
Global
From €2769EUR$3,150USD£2,414GBP
- Report
- October 2024
- 160 Pages
Global
From €5591EUR$6,360USD£4,873GBP
€6989EUR$7,950USD£6,091GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2637EUR$3,000USD£2,299GBP
€3297EUR$3,750USD£2,873GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2637EUR$3,000USD£2,299GBP
€3297EUR$3,750USD£2,873GBP
- Report
- April 2024
- 30 Pages
China
From €1582EUR$1,800USD£1,379GBP
€1978EUR$2,250USD£1,724GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1407EUR$1,600USD£1,226GBP
€1758EUR$2,000USD£1,532GBP
- Report
- February 2024
- 30 Pages
Global
From €2286EUR$2,600USD£1,992GBP
€2857EUR$3,250USD£2,490GBP
- Report
- April 2023
- 180 Pages
Global
From €2110EUR$2,400USD£1,839GBP
€2637EUR$3,000USD£2,299GBP
- Report
- September 2022
- 141 Pages
Global
From €3341EUR$3,800USD£2,912GBP
€4176EUR$4,750USD£3,639GBP
- Report
- February 2022
- 210 Pages
Global
From €5275EUR$6,000USD£4,597GBP
€6593EUR$7,500USD£5,747GBP
- Report
- April 2023
- 120 Pages
Global
From €4176EUR$4,750USD£3,639GBP
- Report
- April 2023
- 110 Pages
Global
From €4176EUR$4,750USD£3,639GBP
The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
